| Name | Title | Contact Details |
|---|---|---|
Todd Morrow |
Chief Information Officer | Profile |
Todd Morrow |
President and Chief Information Officer | Profile |
Tyler Whatcott |
Chief Technology Officer | Profile |
URAC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Enroll & Order Refill Transfer Clinics & Providers Step 1 Create Account: Fill out the “Create Web Account” section here and verify your email Step 2 Complete Enrollment: Select “Enroll” on your account page with all the necessary information Step 3 Su...
Panoramic Health is the nation`s leading integrated value-based kidney care platform led by physicians. The company is committed to keeping nephrologists independent, relevant, and at the center of patient-care delivery; improving outcomes and slowing disease progression for CKD-ESKD patients. Panoramic Health`s value-based care delivery platform is driven by proprietary, predictive data analytics and clinical workflows underpinned by one of the world`s largest clinical CKD data warehouses that enable nephrologists to deliver better patient outcomes and value-based care.
MedSource Consulting is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.